PROGRAM SUSPENSION DIN 02057832
Status: Cancelled Post Market
Holder: ELANCO CANADA LIMITED
Health Canada record
| Active ingredient(s) | LUFENURON 133 MG |
|---|
| Dosage form | Suspension |
|---|
| Route | Oral |
|---|
| Schedule | NON-PRESCRIPTION DRUGS |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 31-Dec-1994 |
|---|
| Current status date | 30-Jul-2026 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LUFENURON
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02238928 | PROGRAM | ELANCO CANADA LIMITED | Tablet | LUFENURON 90 MG | Cancelled Post Market |
| 02238927 | PROGRAM | NOVARTIS ANIMAL HEALTH CANADA INC | Tablet | LUFENURON 45 MG | Cancelled Post Market |
| 02238926 | PROGRAM | ELANCO CANADA LIMITED | Tablet | LUFENURON 409.8 MG | Cancelled Post Market |
| 02238925 | PROGRAM | ELANCO CANADA LIMITED | Tablet | LUFENURON 204.9 MG | Cancelled Post Market |
| 02237517 | PROGRAM 40 | ELANCO CANADA LIMITED | Suspension | LUFENURON 40 MG | Cancelled Post Market |
| 02237516 | PROGRAM 80 | ELANCO CANADA LIMITED | Suspension | LUFENURON 80 MG | Cancelled Post Market |
| 02192632 | PROGRAM SUSPENSION | ELANCO CANADA LIMITED | Suspension | LUFENURON 266 MG | Cancelled Post Market |
| 02087359 | PROGRAM TABLETS 204.9MG | NOVARTIS ANIMAL HEALTH CANADA INC | Tablet | LUFENURON 204.9 MG | Cancelled Post Market |
| 02087367 | PROGRAM TABLETS 409.8MG | NOVARTIS ANIMAL HEALTH CANADA INC | Tablet | LUFENURON 409.8 MG | Cancelled Post Market |
| 02087332 | PROGRAM TABLETS 45MG | NOVARTIS ANIMAL HEALTH CANADA INC | Tablet | LUFENURON 45 MG | Cancelled Post Market |
| 02087340 | PROGRAM TABLETS 90MG | NOVARTIS ANIMAL HEALTH CANADA INC | Tablet | LUFENURON 90 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 17496 | 2015-11-20 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 8587 | 2007-02-14 | Supplement to a New Drug Submission (SNDS) | CHANGE IN MANUFACTURING SITE |
| 6800 | 1997-09-05 | New Drug Submission (NDS) | |
Request a quote for PROGRAM SUSPENSION
How to read a Canadian DIN record